PhRMA "SUMMARY DATA" PROPOSAL DROPPED IN KASSEBAUM DRAFT FDA REFORM BILL; OFF-LABEL PROMOTIONS, EXPANDED ACCESS LIKELY TO BE SUBJECT OF FURTHER DEBATE
Executive Summary
PhRMA is planning a campaign to re-insert a provision on NDA "summary data" reports into FDA reform legislation.